Navigation Links
ConvaTec Announces Acquisition of Boston Medical Device
Date:9/1/2011

SKILLMAN, N.J., Sept. 1, 2011 /PRNewswire/ -- ConvaTec Inc., a world-leading developer and marketer of innovative medical technologies for community and hospital care today announced that the company has acquired Boston Medical Device, Inc. (BMD), a distribution company that offers a platform of specialized medical devices throughout Latin America.

More than 30 years of management experience building relationships in key Latin American markets, coupled with strong market share in both wound and ostomy care products, have enabled BMD to maintain market leadership and positions the company well for growth and expansion.  BMD is the current exclusive distributor of ConvaTec products for Latin America, making it an ideal complement to ConvaTec as the company continues to pursue growth in emerging markets.

"Emerging markets, particularly Latin America, are an increasingly important growth component for ConvaTec," stated Nino Pionati, President, ConvaTec Intercontinental. "Today's announcement is a reflection of that strategic priority as well as recognition of the market leadership that BMD has achieved and maintained in this region over the years."

"BMD is excited to become part of the ConvaTec family and to be able to work even more closely with ConvaTec to continually provide the quality products and services our customers have come to expect, and that the patients who use our products on a daily basis deserve," stated Erich Roht, President and CEO, BMD.

In keeping with our commitment to our customers, there will be no impact on current orders and delivery schedules. Business will continue as normal and both companies are committed to ensuring our customers and their patients continue to receive the ConvaTec products that they have come to know and trust.

About ConvaTec Inc.ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.

About Boston Medical Device, Inc. Boston Medical Device, Inc. (BMD) is a leading promoter and distributor of specialized medical devices and related healthcare products and services on a Pan-Latin America basis. The Company has wholly owned subsidiaries across Latin American that focuses their efforts on sales, marketing and distribution. BMD has more than 170 employees in nine countries across Latin America.Media Contact:Investor Relations Contact:Nimisha SavaniTim Winston1-908-904-25221-908-904-2988mediarelations@convatec.com

investorrelations@convatec.com
'/>"/>

SOURCE ConvaTec Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Healthcare Announces 2011 Second Quarter Earnings Call
2. ConvaTec Announces Asia-Pacific Leadership Appointments
3. Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technology™ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients
4. ConvaTec Healthcare Announces 2011 First Quarter Earnings Call
5. ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
6. ConvaTec Announces Acquisition of Trent Direct
7. ConvaTec Healthcare Announces 2010 Year-End Earnings Call
8. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
9. Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care
10. ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans
11. ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):